Targeting MYC for triple-negative breast cancer treatment
Oncoscience
.
2018 Jun 23;5(5-6):120-121.
doi: 10.18632/oncoscience.414.
eCollection 2018 May.
Authors
Nancy Klauber-DeMore
1
,
Bradley A Schulte
1
,
Gavin Y Wang
1
Affiliation
1
Developmental Cancer Therapeutics (DCT) Program, Hollings Cancer Center; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
PMID:
30035158
PMCID:
PMC6049315
DOI:
10.18632/oncoscience.414
No abstract available
Keywords:
JQ1; MYC; cancer stem cells; triple-negative breast cancers (TNBC); triptolide.
Publication types
Editorial
Grants and funding
P20 GM103542/GM/NIGMS NIH HHS/United States
T32 GM008716/GM/NIGMS NIH HHS/United States
UL1 TR001450/TR/NCATS NIH HHS/United States